We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPRA
1451
Opera Ltd
OPRA
$1.79B
| $618K | ﹤0.01% |
+66,861
| New | +$656K |
|
1452
BCB Bancorp
BCBP
$161M
| $617K | ﹤0.01% |
44,754
+5,200
| +13% | +$69.1K |
|
1453
Alaunos Therapeutics
TCRT
$4.86M
| $617K | ﹤0.01% |
+871
| New | +$599K |
|
1454
Ring Energy
REI
$339M
| $616K | ﹤0.01% |
+233,500
| New | +$458K |
|
1455
Rithm Capital
RITM
$5.69B
| $612K | ﹤0.01% |
+38,000
| New | +$597K |
|
1456
Take-Two Interactive
TTWO
$46.1B
| $612K | ﹤0.01% |
5,000
+3,000
| +150% | +$365K |
|
|
SRT
1457
DELISTED
Startek Inc.
SRT
| $610K | ﹤0.01% |
76,407
-24,037
| -24% | -$175K |
|
|
FFWM
1458
DELISTED
First Foundation Inc
FFWM
| $605K | ﹤0.01% |
34,784
+1,849
| +6% | +$29.8K |
|
1459
ResMed
RMD
$30.7B
| $604K | ﹤0.01% |
+3,900
| New | +$562K |
|
1460
MDU Resources
MDU
$4.32B
| $603K | ﹤0.01% |
53,387
-55,490
| -51% | -$606K |
|
|
NWLI
1461
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $601K | ﹤0.01% |
2,067
| – | – |
|
1462
Schneider National
SNDR
$6.25B
| $599K | ﹤0.01% |
27,451
+1,051
| +4% | +$23.6K |
|
1463
Alaska Air
ALK
$5.58B
| $596K | ﹤0.01% |
+8,800
| New | +$601K |
|
1464
Embotelladora Andina Series B
AKO.B
$4.95B
| $594K | ﹤0.01% |
33,915
-6,148
| -15% | -$106K |
|
1465
Fulgent Genetics
FLGT
$527M
| $594K | ﹤0.01% |
+46,021
| New | +$547K |
|
1466
FS Bancorp
FSBW
$320M
| $586K | ﹤0.01% |
+18,370
| New | +$533K |
|
1467
FirstService
FSV
$6.32B
| $586K | ﹤0.01% |
+6,300
| New | +$593K |
|
|
KE
1468
Kimball Electronics
KE
$628M
| $581K | ﹤0.01% |
+33,108
| New | +$544K |
|
1469
Denali Therapeutics
DNLI
$3.97B
| $579K | ﹤0.01% |
+33,242
| New | +$553K |
|
1470
Integer Holdings
ITGR
$4.26B
| $571K | ﹤0.01% |
+7,104
| New | +$542K |
|
1471
Valhi
VHI
$450M
| $565K | ﹤0.01% |
25,176
-3,748
| -13% | -$86K |
|
|
CKH
1472
DELISTED
Seacor Holdings Inc.
CKH
| $560K | ﹤0.01% |
+12,967
| New | +$567K |
|
|
MNTA
1473
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $559K | ﹤0.01% |
+28,321
| New | +$453K |
|
1474
Zymeworks
ZYME
$1.67B
| $558K | ﹤0.01% |
+12,264
| New | +$446K |
|
1475
Nicolet Bankshares
NIC
$3.62B
| $547K | ﹤0.01% |
+7,412
| New | +$522K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.